Tirzepatide Research Guide
Overview
Tirzepatide is a dual GLP-1/GIP receptor agonist representing a major advancement in incretin research. This “twincretin” mechanism enables investigation of synergistic metabolic effects impossible with single-receptor agonists.
Dual Receptor Mechanism
- GLP-1 Receptor: Appetite suppression and glucose-dependent insulin secretion
- GIP Receptor: Enhanced insulin sensitivity and lipid metabolism
Quality Standards
- Purity: >99% verified by HPLC
- Form: Lyophilized powder
- Storage: -20°C long-term, 2-4 weeks reconstituted at 4°C
- Documentation: Full CoA included
For research purposes only. Not for human consumption.







James T. — United Kingdom (verified owner) –
The dual agonist effect is noticeable even at a low dose. Quality sourcing is clearly a priority here.
Adam W. — China (verified owner) –
I was skeptical at first but the quality speaks for itself. Already placed my second order.